Question 1

What is the IPO lifecycle, and what does this page map?

Accepted Answer

The IPO lifecycle is the sequence of legal and market steps by which a private company first offers its shares to the public. The SEC's investor bulletin on IPOs describes the arc: the company files a registration statement with the SEC (typically Form S-1) that contains the prospectus; the SEC staff reviews it and the review often results in revisions; once staff comments are addressed the staff issues an order declaring the registration statement effective; the underwriters, having gathered indications of interest, recommend a price that the issuer ultimately determines; the company usually applies to list its shares on an exchange such as the New York Stock Exchange or Nasdaq; and the new public company becomes subject to ongoing disclosure on Forms 10-Q and 10-K. This page is the map of that arc and an index to the fourteen detailed stages that follow; it sets out the connective framework — Section 5 of the Securities Act of 1933 and the effective date under Section 8(a) — and does not restate each stage in depth, because each stage has its own page. The bulletin states that the SEC's declaration of effectiveness does not represent an approval of the merits of the IPO or an indication that the disclosed information is complete or accurate, and that the staff does not evaluate whether an investment is appropriate for any investor; responsibility for complete and accurate disclosure lies with the company and others who prepare the registration statement and prospectus.

Question 2

What legal framework connects the whole IPO process?

Accepted Answer

Section 5 of the Securities Act of 1933 governs the entire offering and divides it into three periods keyed to the registration statement. In the pre-filing period, before a registration statement is filed, Section 5(c) makes it unlawful to offer to sell or offer to buy the security. In the waiting period, after filing but before the registration statement is effective, Section 5(b)(1) permits offers but requires any written offer to be a prospectus that meets Section 10. Section 5(a) makes it unlawful to sell the security unless a registration statement is in effect, so sales occur only in the post-effective period. These three periods — defined by the filing date and the effective date of the registration statement — are the connective tissue that sequences the individual IPO stages. The confidential-submission and testing-the-waters mechanisms operate in or before the pre-filing period; the S-1 filing opens the waiting period, during which SEC staff review, the parallel exchange-listing and FINRA reviews, waiting-period communications, and the road show occur; pricing is set at effectiveness; and stabilization, the over-allotment option, lock-up agreements, research quiet periods, and reporting-company obligations operate in the post-effective period.

Question 3

What is a registration statement, and why is it the spine of the process?

Accepted Answer

A registration statement is the disclosure document a company files with the SEC to register a securities offering under the Securities Act of 1933; for an IPO it is most commonly SEC Form S-1, and it includes the prospectus used to offer the securities. Section 5(a) makes it unlawful to sell a security unless a registration statement is in effect, and Section 5(c) makes it unlawful to offer the security before a registration statement has been filed — so the registration statement is the document the entire process revolves around. Section 7 of the Securities Act specifies the information and documents the registration statement must contain (through the requirements of Schedule A), and Section 10 governs the information required in the prospectus. The Investor.gov bulletin states that under the federal securities laws a company may not lawfully offer or sell shares unless the transaction has been registered with the SEC or an exemption applies, and that the company files a registration statement, typically Form S-1, an important part of which is the prospectus used to solicit investors. The detailed contents and eligibility of Form S-1 are covered in the S-1 Filing stage.

Question 4

When and how does a registration statement become effective?

Accepted Answer

The effective date of the registration statement is the pivot of the IPO lifecycle: offers are permitted during the waiting period, but sales may occur only after the registration statement is effective. Section 8(a) of the Securities Act provides that the effective date shall be the twentieth day after the filing thereof, or such earlier date as the Commission may determine — so in practice the SEC accelerates effectiveness, declaring the registration statement effective, once staff review is complete and the issuer requests acceleration. Because any amendment filed before the effective date is treated under Section 8(a) as restarting the filing for timing purposes, IPO registration statements are, in practice, declared effective by the SEC on an accelerated basis. The Investor.gov bulletin states that once staff comments have been addressed the staff will issue an order declaring the registration statement effective, which means the company may proceed to consummate its IPO, and that the declaration of effectiveness does not represent an approval of the merits of the IPO. Pricing is typically set at or just before effectiveness under Securities Act Rule 430A, which allows the effective registration statement to omit the offering price, with the price supplied in a prospectus filed under Rule 424(b).

Question 5

Where does the lifecycle begin — the decision to go public?

Accepted Answer

The lifecycle begins when a private company decides to raise capital through a registered public offering. The SEC's going-public guidance states that if a company decides to conduct a registered public offering, the Securities Act requires it to file a registration statement with the SEC before it may offer its securities for sale, and that the company may not actually sell the securities covered by the registration statement until the SEC staff declares the registration statement effective. Going public also makes the company subject to ongoing public reporting obligations, so the SEC guidance frames the decision around the registration requirement, the filing-review process, and the post-offering reporting obligations. This page maps the registered-IPO path; Securities Act-exempt routes to raising capital (for example, exempt offerings under Regulation A or Regulation D) follow different frameworks and are outside the scope of the registered-IPO lifecycle described here.

Question 6

How do the confidential-draft and public-filing stages fit the arc?

Accepted Answer

Three stages take the company from a private draft to a public filing. In the confidential submission stage, an eligible issuer submits a draft registration statement to the SEC's Division of Corporation Finance for nonpublic staff review before anything is filed publicly on EDGAR. In the testing-the-waters stage, the issuer or persons authorized to act on its behalf may communicate with certain institutional investors to gauge interest. The S-1 filing stage is the public filing of the registration statement on EDGAR, which opens the Section 5 waiting period. The draft registration statement accommodation is available for an IPO under the Division of Corporation Finance's policy and is statutory for emerging growth companies under Securities Act Section 6(e). Testing-the-waters communications by emerging growth companies are authorized by Securities Act Section 5(d), and Securities Act Rule 163B extends a testing-the-waters accommodation to all issuers. Each of these stages is covered in depth on its own page: Confidential Submission of a Draft Registration Statement, Testing the Waters, and S-1 Filing.

Question 7

What happens during SEC staff review?

Accepted Answer

After the registration statement is filed, the SEC's Division of Corporation Finance staff reviews it and may issue comment letters. The Investor.gov bulletin states that registration statements for IPOs are subject to review by the SEC staff to monitor compliance with applicable disclosure requirements, that the staff concentrates on disclosures that appear to conflict with SEC rules or applicable accounting standards or to be materially deficient in explanation or clarity, and that the staff's review often results in revisions to the prospectus. The bulletin also states that the review process is not a guarantee that a company's disclosure is complete or accurate and that the staff does not evaluate the merits of any IPO or determine whether an investment is appropriate for any investor. The comment-and-response process, the forms and levels of review, and the resolution of comments are covered in depth in the SEC Comment Letters stage; the staff issues an order declaring the registration statement effective once the comments have been addressed.

Question 8

What parallel regulatory reviews run alongside SEC staff review?

Accepted Answer

Two regulatory reviews run in parallel with SEC staff review rather than after it. To list the shares, the issuer applies to a national securities exchange — such as the New York Stock Exchange or Nasdaq — and registers the class under Section 12(b) of the Securities Exchange Act of 1934, which provides that a security is registered by the issuer filing an application with the exchange. Separately, FINRA reviews the underwriting terms and arrangements of most public offerings under FINRA Rule 5110, the Corporate Financing Rule. The Investor.gov bulletin notes that in conjunction with an IPO a company usually applies to list its shares on an established stock exchange and that any planned listing is typically disclosed in the prospectus. FINRA — the self-regulatory organization that oversees U.S. broker-dealers under SEC supervision — must have no objection to the underwriting terms and arrangements before a participating member proceeds with the offering. The exchange listing standards and application are covered in the Exchange Listing Application stage, and the mechanics of Rule 5110 in the FINRA Corporate Financing Review stage; the FINRA rule is described and linked here, not reproduced.

Question 9

How is the offering marketed once the registration statement is public?

Accepted Answer

Once the registration statement is on public file, the offering is marketed during the Section 5 waiting period under communication limits. Section 5(b)(1) permits oral offers and requires any written offer to be a prospectus that meets Section 10, with additional written offering materials permitted as free writing prospectuses under the SEC's rules. Management presents the offering to prospective investors in a road show, which Securities Act Rule 433(h)(4) defines as an offer containing a presentation regarding the offering by one or more members of the issuer's management. Because a road show and other offering communications are offers, they are governed by Section 5. The permitted forms of oral and written communication in the waiting period are covered in the Waiting-Period Communications stage, and the road show — live versus written or electronic, and the related public-availability conditions — in the IPO Road Show stage. The issuer's pre-filing quiet period and the separate research-analyst quiet periods are addressed in the Research Quiet Periods and Analyst Rules stage.

Question 10

How is the IPO priced and allocated?

Accepted Answer

The offering is priced at the end of the marketing period. The Investor.gov bulletin states that the underwriters typically will have obtained indications of interest from prospective investors prior to effectiveness and will use that information to recommend a price for the shares to the issuer, who ultimately determines the price of the IPO. Securities Act Rule 430A allows the registration statement to be declared effective with the offering price omitted, provided the price-dependent information is supplied in a prospectus filed under Rule 424(b). Rule 430A (17 CFR 230.430A) permits the form of prospectus in an effective registration statement to omit information dependent on the offering price — including the public offering price, underwriting discounts or commissions, and the amount of proceeds — for securities offered for cash, provided that information is contained in a prospectus filed with the Commission under Rule 424(b) within the rule's time limits. The demand-gathering, bookbuilding, and price-setting mechanics are covered in the Bookbuilding and Pricing stage; the bulletin describes that underwriters and dealers often distribute most of the shares to their institutional and high-net-worth clients.

Question 11

What mechanisms operate around the first trade and the aftermarket?

Accepted Answer

When the offering closes, the shares begin trading and several mechanisms operate around the first trade and the aftermarket. Under SEC Regulation M, Rule 104 permits a distributor to place a stabilizing bid solely to prevent or retard a decline in the market price. The underwriting agreement may include an over-allotment (greenshoe) option to buy additional shares at the offering price. Lock-up agreements restrict insiders from selling for a set period, and research quiet periods limit analyst reports around the offering. Regulation M Rule 104 (17 CFR 242.104) is the one narrowly permitted price-influencing activity in a U.S. offering; the over-allotment arrangement is disclosed under Regulation S-K Item 508 (17 CFR 229.508); lock-up agreements are contractual arrangements typically between the underwriters and the issuer's officers, directors, and pre-IPO shareholders, as described in the SEC's investor materials; and research quiet periods arise under FINRA and exchange rules together with the Securities Act Section 5 framework. Each is covered in depth in its own stage: Stabilization and Syndicate Activity, Over-Allotment (Greenshoe) Option, IPO Lock-Up Agreements, and Research Quiet Periods and Analyst Rules.

Question 12

What does the company become after the IPO closes?

Accepted Answer

After the IPO, the company becomes a reporting company subject to ongoing disclosure under the Securities Exchange Act of 1934. The effective Securities Act registration statement triggers periodic reporting under Section 15(d), and registering the listed class on Form 8-A under Section 12(b) triggers reporting under Section 13(a). The company then files annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K on an ongoing basis. The SEC's going-public guidance states that after an IPO the company's obligations include annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K, and that the company's CEO and CFO must certify the financial and certain other information in the Form 10-K and Form 10-Q. The full set of post-IPO reports, filers, and deadlines — including the Section 16 insider reports and the Schedule 13D and 13G beneficial-ownership reports — is covered in the Becoming a Reporting Company stage, the endpoint of the lifecycle.

#	Stage	Section 5 period	What it covers	Primary authority
1	Confidential Submission of a Draft Registration Statement	Pre-filing	Nonpublic SEC staff review of a draft registration statement before public filing on EDGAR	SEC — Draft Registration Statement FAQs · source
2	Testing the Waters	Pre-filing	Communications with certain institutional investors to gauge interest before or after filing	17 CFR 230.163B · source
3	S-1 Filing	Filing (opens waiting period)	Public filing of the Securities Act registration statement on EDGAR	SEC Form S-1, General Instructions · source
4	SEC Comment Letters	Waiting period	SEC staff review comments on the filing and the issuer's responses and revisions	SEC — The Filing Review Process · source
5	Exchange Listing Application	Waiting period (parallel)	Application to list the shares and registration of the class under Exchange Act Section 12(b)	Exchange Act Section 12(b) (govinfo) · source
6	FINRA Corporate Financing Review	Waiting period (parallel)	FINRA review of the underwriting terms and arrangements of the offering	FINRA Rule 5110 (Corporate Financing Rule) · source
7	Waiting-Period Communications	Waiting period	Permitted oral and written offering communications between filing and effectiveness	Securities Act Section 5(b) (govinfo) · source
8	IPO Road Show	Waiting period	Management's offering presentations to prospective investors	17 CFR 230.433 · source
9	Bookbuilding and Pricing	At effectiveness	Gathering indications of interest and setting the offering price; price-omission mechanics	17 CFR 230.430A · source
10	Stabilization and Syndicate Activity	Post-effective	Permitted stabilizing bids under Regulation M Rule 104	17 CFR 242.104 · source
11	Over-Allotment (Greenshoe) Option	Post-effective	Underwriters' option to buy additional shares at the offering price	17 CFR 229.508 (Regulation S-K Item 508) · source
12	IPO Lock-Up Agreements	Post-effective	Contractual restrictions on insider share sales for a set period after the offering	SEC / Investor.gov — Lockup Agreements · source
13	Research Quiet Periods and Analyst Rules	Post-effective	Limits on the publication of analyst research reports around the offering	FINRA Rule 2241 (Research Analysts and Research Reports) · source
14	Becoming a Reporting Company	Post-IPO (ongoing)	Ongoing Exchange Act reporting on Forms 10-K, 10-Q, and 8-K	SEC — Exchange Act Reporting and Registration · source

Explore 1BusinessWorld

Welcome to 1BusinessWorld

IPO Lifecycle